Related Experiment Video
Updated: Aug 7, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Invasive fungal infections in patients with acute leukemia
Hui-Hua Hsiao1, Hui-Jen Tsai, Yi-Chang Liu
1Division of Hematology-Oncology, Kaohsiung Medical University Chun-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Abstract:
Invasive fungal infections, a serious problem among cancer patients, are increasing in incidence, and can cause morbidity and mortality. Such infections may hinder additional treatment, especially for patients with leukemia. We report here our experiences in the management of invasive fungal infection in patients with acute leukemia. A total of 18 patients were enrolled in the study: 12 had microabscesses of the liver and/or spleen and/or kidneys; four had sinonasal infections; and two had pulmonary infections. Most of the patients (88.9%) received amphotericin B during treatment for fungal infection. Thirteen patients achieved complete response without evidence of fungal infection in follow-up. In the study, there were 11 mortalities, including five patients who died during therapy and six who later died as a result of relapse or refractoriness of the leukemia. We suggest that many patients may have a good response to antifungal therapy, and that fungal infection does not have to preclude additional chemotherapy after proper management. The state of the underlying disease has a strong impact on outcome.
Insights
Invasive fungal infections are a significant threat to cancer patients, particularly those with leukemia. Antifungal therapy, like amphotericin B, can lead to a good response, allowing for continued chemotherapy.
Area of Science:
- Oncology
- Infectious Diseases
- Hematology
Background:
- Invasive fungal infections (IFIs) pose a serious threat to cancer patients, increasing morbidity and mortality.
- IFIs can impede crucial treatments, especially for patients undergoing leukemia therapy.
Purpose of the Study:
- To evaluate the management and outcomes of invasive fungal infections in patients with acute leukemia.
- To determine the efficacy of antifungal therapy in this vulnerable patient population.
Main Methods:
- Retrospective analysis of 18 patients with acute leukemia and invasive fungal infections.
- Treatment involved amphotericin B in 88.9% of cases, targeting various infection sites (liver, spleen, kidney, sinonasal, pulmonary).
Main Results:
- Thirteen patients achieved a complete response to antifungal therapy.
- Eleven patients (61.1%) experienced mortality, with causes including treatment complications and leukemia relapse/refractoriness.
- Underlying disease status significantly impacted patient outcomes.
Conclusions:
- Antifungal therapy can be effective in managing invasive fungal infections in acute leukemia patients.
- Successful management of fungal infections may permit continuation of chemotherapy, improving patient prognosis.
- Prompt and appropriate antifungal treatment is crucial for improving outcomes in leukemia patients with IFIs.
More Related Videos
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Candidiasis
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

